Julian Risch

Dr. Julian Risch

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2025 in Current Oncology
Verified
Journal Article
Open access
PDF file
LBLeonhard Buck
Leonhard Buck
JKJakob Kohler
Jakob Kohler
JRJulian Risch
Julian Risch
RIReha-Baris Incesu
Reha-Baris Incesu
KHKonrad Hügelmann
Konrad Hügelmann
SRSeverin Rodler
Severin Rodler
Background: Multimodal artificial intelligence (MMAI) is transforming urological oncology by enabling the seamless integration of diverse data sources, including imaging, clinical records and robotic telemetry to facilitate patient-specific decision-making. Methods: This narrative review summarizes the current developments, applications, opportunities and risks of multimodal AI systems throughout the entire perioperative process in uro-oncologic surgery. Results: MMAI demonstrates quantifiable benefits across the entire perioperative pathway. Preoperatively, it improves diagnostics and surgical planning via multimodal data fusion. Intraoperatively, AI-assisted systems provide real-time context-based decision support, risk prediction and skill assessment within the operating theater. Postoperatively, MMAI facilitates automated documentation, early complication detection and personalized follow-up. Generative AI further revolutionizes surgical training through adaptive feedback and simulations. However, critical limitations must be addressed, including data bias, the barrier of closed robotic platforms, insufficient model validation, data security issues, hallucinations and ethical concerns regarding liability and transparency. Conclusions: MMAI significantly enhances the precision, efficiency and patient-centeredness of uro-oncological care. To ensure safe and widespread implementation, resolving the technical and regulatory barriers to real-time integration into robotic platforms is paramount. This must be coupled with standardized quality controls, transparent decision-making processes and responsible integration that fully preserves physician autonomy.

9 October 2025 in Urologia Internationalis
Verified
Journal Article
Closed access
JRJulian Risch
Julian Risch
KHKonrad Hügelmann
Konrad Hügelmann
LBLeonhard Buck
Leonhard Buck
HKHans-Christoph von Knobloch
Hans-Christoph von Knobloch
JKJakob Kohler
Jakob Kohler
SRSeverin Rodler
Severin Rodler
Introduction: Patient education materials (PEMs) play a vital role in ensuring that patients understand their medical conditions and treatment options. In prostate cancer, complex medical terminology can hamper comprehension and informed decision-making. This study evaluates the readability of prostate cancer PEMs to determine if they meet recommended standards for lay audiences. Methods: A selection of standardized prostate cancer PEMs, including standard surgical consent forms and patient brochures from major German cancer organizations, was analyzed. Readability was assessed using established metrics, including the Flesch Reading Ease Score (FRES), Flesch-Kincaid Grade Level (FKGL), Gunning Fog Score (GFS), Simple Measure of Gobbledygook (SMOG) Index, Coleman-Liau Index (CLI), and Automated Readability Index (ARI). Layperson readability was defined as a FRES of 70 (at or below a seventh-grade reading level) and the other readability indexes ≤7, following European Union recommendations. Results: The readability of prostate cancer PEMs of both surgical consent forms and patient brochures did not meet the recommended thresholds set by the European Union for layperson summaries. The median FRES for consent forms was 25.9 (SD: 1.52), ranging from 24.3 (prostate biopsy) to 28.0 (open RPx). Patient brochures showed a median FRES of 23.2 (SD: 2.87), with scores of 23.2 (German Cancer Aid), 22.5 (DKFZ), and 28.9 (S3-Guidelines). Section-specific values varied, with the highest FRES observed in the “Basic Explanation and Screening” section of the S3-Guidelines (39.0, SD: 7.09) and the lowest in the “Follow-Up” section of the German Cancer Aid brochure (15.8, SD: 10.35). All grade-level metrics (FKGL, GFS, SMOG, CLI, ARI) exceeded the recommended level of grade 7. Conclusion: The readability of prostate cancer PEMs in Germany falls short of recommended thresholds for lay comprehension. To enhance clarity and accessibility, the use of automated readability tools and standardized benchmarks (e.g., FRES ≥70, grade level ≤7) is recommended. Involving multidisciplinary teams may further support the development of patient-centered content. Future research should combine readability metrics with patient feedback to evaluate real-world comprehension and usability.

16 June 2026 in Urologia Internationalis
Verified
Journal Article
Closed access
JRJulian Risch
Julian Risch
DJDavid Jacobi
David Jacobi
JKJakob Kohler
Jakob Kohler
LBLeonhard Buck
Leonhard Buck
KHKonrad Hügelmann
Konrad Hügelmann
SRSeverin Rodler
Severin Rodler
Introduction: Digital transformation of European healthcare is progressing rapidly, yet implementation in outpatient specialist care remains uneven. In Germany, office-based urologists face distinct structural, regulatory and economic challenges. We assessed digital infrastructure, tool utilization, perceived barriers and investment behaviour, including age-related differences. Methods: We conducted a nationwide cross-sectional survey (April–July 2024) among private-practice urologists in Germany using a 35-item questionnaire structured along three dimensions of digital adoption (infrastructure, functional use, physician attitudes). Items were adapted from two previously published, peer-reviewed German urology surveys and pretested with 12 urologists prior to launch. 189 valid responses (response rate 17.4%) were analysed using descriptive statistics, chi-squared tests and pre-specified multivariable logistic regression adjusting for age, gender, practice size, years in practice and region. Results: Self-reported digital familiarity was high (66.1% familiar or very familiar), yet infrastructure remained traditional: 92.6% used on-site servers and only 7.4% any cloud component. Telemedicine was rarely used (61.9% never), while 49.2% used health apps or DiGAs. Adjusted analyses confirmed that age <55 years (aOR 2.93, 95% CI 1.56–5.52, p<0.001) and shorter time in practice (aOR 0.78 per +5 years, 95% CI 0.65–0.94, p=0.009) independently predicted DiGA use and revealed that telemedicine adoption was driven primarily by practice size (aOR 1.16 per additional full-time equivalent, 95% CI 1.05–1.29, p=0.005) rather than age. Most practices planned to invest less than €30,000 over five years. Conclusions: Digitalization in outpatient urology remains primarily administrative. High familiarity does not translate into clinical transformation, and adoption is constrained by structural rather than generational barriers. Targeted funding, interoperable systems, and clear reimbursement frameworks are needed to enable clinically meaningful digital integration.

2 October 2026 in BJUI Compass
Verified
Journal Article
Open access
JRJulian Risch
Julian Risch
KHKonrad Hügelmann
Konrad Hügelmann
LBLeonhard Buck
Leonhard Buck
HKHans‐Christoph von Knobloch
Hans‐Christoph von Knobloch
JKJakob Kohler
Jakob Kohler
SRSeverin Rodler
Severin Rodler
Objectives: This study aims to assess patient acceptance of intraoperative video recording with Operating Room (OR) black box technology, characterise consent conditions and use‐case preferences, and identify predictors of patient confidence in artificial intelligence (AI)‐assisted surgery in urological patients. Patients and Methods: This prospective cross‐sectional survey was conducted at the urology department of a university hospital from March 2024 to March 2025. Consecutive adults scheduled for elective procedures were enrolled (322 enrolled; 316 completed the binary consent item). A standardised questionnaire assessed consent to operative video storage and attitudes across four Likert‐scaled domains (29 items: consent conditions, use cases, data access and AI confidence). The primary outcome was confidence in AI‐assisted surgery for the full procedure. Analysis included Wilson 95% confidence intervals, between‐group comparisons and multivariable linear regression. Results: Of 316 patients (82.9% male, mean age 65.4 years), 304 (96.2%, 95% CI 93.5–97.8%) consented to operative video storage, with universal acceptance among oncological patients (181/181, 100%). Nonconsenters ( n = 12) were younger, without oncological diagnosis and reported lower AI confidence. All 29 attitudinal items received majority endorsement. Patient confidence in AI‐assisted surgery was expressed by 55.2% for the full procedure, 63.5% for simple steps and 53.9% for complex steps ( p < 0.001). Older patients expressed greater confidence ( r ₛ = −0.21, p < 0.001). Age and three attitudinal composites independently predicted AI confidence (adjusted R 2 = 0.308), whereas demographic and clinical characteristics accounted for only 5.8% of variation. Conclusion: Urological patients broadly accept intraoperative recording and AI‐assisted surgery when transparent governance is ensured. Attitudinal factors outweigh demographic and clinical characteristics, supporting patient‐centred consent frameworks for OR black box implementation in urological practice.

24 April 2026 in Urologia Internationalis
Verified
Journal Article
Closed access
JKJakob Kohler
Jakob Kohler
FRFrank Regenhardt
Frank Regenhardt
LBLeonhard Buck
Leonhard Buck
KHKonrad Hügelmann
Konrad Hügelmann
RIReha-Baris Incesu
Reha-Baris Incesu
SRSeverin Rodler
Severin Rodler
Background and Objective In penile cancer, guideline-concordant invasive nodal staging in clinically node-negative (cN0) patients must balance diagnostic value against perioperative harm. We quantified early perioperative outcomes within a guideline-concordant nodal staging pathway, comparing primary dynamic sentinel node biopsy/sentinel lymph-node excision (DSNB/SLNE) with completion inguinal lymph-node dissection (ILND) performed after sentinel node positivity in a stage-restricted pT1b+ cohort. Methods Single-center retrospective observational cohort study at a tertiary referral center, January 2013–December 2024. Of 127 screened patients undergoing any groin procedure, 98 had complete datasets; the primary analysis was restricted to pT1b+ disease (n = 61). Primary outcomes were 30-day major complications (Clavien–Dindo ≥III) and length of stay (LOS). Secondary outcomes were type-specific complications, unplanned readmission, and reoperation. Outcomes were captured per procedure using distinct 30-day windows. Paired within-patient analyses used exact McNemar and Wilcoxon signed-rank tests; unpaired sensitivity analyses used Fisher’s exact and Welch’s t-tests. Key Findings and Limitations In the pT1b+ cohort, 61 patients underwent primary SLNE/DSNB, and 30 subsequently underwent completion ILND after sentinel node positivity. For perioperative analyses, procedures were evaluated at the procedure level (61 SLNE procedures; 30 completion ILND procedures). Major complications occurred in 4/61 (6.7%) after SLNE versus 8/30 (26.7%) after completion ILND (absolute difference 20.0 percentage points; Fisher’s exact p = 0.0175). In paired analyses (n = 30), discordant events favored SLNE (matched OR 0.12, 95% CI 0.02–1.00; exact McNemar p = 0.039). LOS was longer after completion ILND; the paired median within-patient difference was +6 days (Wilcoxon p = 0.000238), and unpaired analyses showed a mean difference of approximately +8.68 days (Welch’s t-test p = 0.00273). Completion ILND had higher 30-day rates of lymphocele, reoperation, readmission, infection, impaired wound healing, skin necrosis, and sepsis. Conclusions and Clinical Implications In a guideline-aligned cN0, pT1b+ pathway, primary DSNB/SLNE was associated with substantially lower early perioperative burden than completion ILND after sentinel node positivity while identifying the subgroup requiring therapeutic escalation. These findings quantify the additional morbidity associated with escalation after positive sentinel staging rather than a head-to-head comparison of equivalent primary strategies.